Mapping Which Coronavirus Variants Will Resist Antibody Treatments
Caption: The antibody LY-CoV016 (purple) is bound to RBD. This “escape map” indicates where in the viral RBD new mutations are most likely to make LY-CoV016 less effective (red). It also shows places...
View ArticleSouth Africa Study Shows Power of Genomic Surveillance Amid COVID-19 Pandemic
Credit: iStock/Thomas Faull Considerable research is underway around the world to monitor the spread of new variants of SARS-CoV-2, the coronavirus that causes COVID-19. That includes the variant...
View ArticleInfections with ‘U.K Variant’ B.1.1.7 Have Greater Risk of Mortality
Since the genome sequence of SARS-CoV-2, the virus responsible for COVID-19, was first reported in January 2020, thousands of variants have been reported. In the vast majority of cases, these...
View ArticleA Real-World Look at COVID-19 Vaccines Versus New Variants
Credit: Getty Images/Andrey Popov Clinical trials have shown the COVID-19 vaccines now being administered around the country are highly effective in protecting fully vaccinated individuals from the...
View ArticleHuman Antibodies Target Many Parts of Coronavirus Spike Protein
Caption: People who recovered from mild COVID-19 infections produced antibodies circulating in their blood that target three different parts of the coronavirus’s spike protein (gray). Credit:...
View ArticleStudies Confirm COVID-19 mRNA Vaccines Safe, Effective for Pregnant Women
Credit: GettyImages/bogdankosanovic Clinical trials have shown that COVID-19 vaccines are remarkably effective in protecting those age 12 and up against infection by the coronavirus SARS-CoV-2. The...
View ArticleHow Immunity Generated from COVID-19 Vaccines Differs from an Infection
A key issue as we move closer to ending the pandemic is determining more precisely how long people exposed to SARS-CoV-2, the COVID-19 virus, will make neutralizing antibodies against this dangerous...
View Article
More Pages to Explore .....